Sana Biotechnology Inc (SANA)
Sana Biotechnology Inc (SANA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -144 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -13 | -86 | -138 | -251 | -290 | -254 | -223 | -144 | |
| 0.0 | 1.8 | 5.9 | 11 | 16 | 25 | 17 | 13 | |
| 0.1 | 1.5 | 5.8 | 22 | 38 | 36 | 38 | 25 | |
| 0.1 | 33 | 135 | 51 | 26 | – | – | – | |
| -0.3 | 11 | 6.2 | 9.8 | 7.5 | 19 | -1.2 | -10 | |
| 0.5 | 26 | 24 | 30 | 21 | 20 | 33 | 0.9 | |
| -0.8 | -88 | -253 | -246 | 211 | 172 | 17 | -40 | |
| – | – | – | 626 | 0.6 | – | – | – | |
| – | – | – | – | 0.0 | 27 | 7.7 | 126 | |
| 46 | 224 | 436 | 632 | 4.9 | 32 | 200 | 129 | |
| 31 | 50 | 45 | 135 | -75 | -50 | -6.0 | -55 | |
| -14 | -112 | -162 | -281 | -311 | -274 | -257 | -145 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.